GPNX
NOTIFICATION PROCESSED BY IB
12/25/2021
Back to search
Official data from USPTO
XEGEMDI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
12/25/2021
Trademark type
Word
Nice classes
5
Filing date
03/12/2021
Registration date
09/28/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2021
Last transaction
09/28/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
TWOHIG,SHANNON MARIE
Law office
N20
Current location
TMO LAW OFFICE 120
Holders and representatives
Holders
TAIHO PHARMACEUTICAL CO., LTD.
Representatives
IWASE Hitomi
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations
Publications
History of USPTO decisions and trademark events.
13 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/06/2021
FIMP
FINAL DISPOSITION PROCESSED
12/06/2021
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
10/28/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/28/2021
PUBO
PUBLISHED FOR OPPOSITION
07/13/2021
NPUB
NOTICE OF PUBLICATION
06/23/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2021
DOCK
ASSIGNED TO EXAMINER
06/02/2021
MAFR
APPLICATION FILING RECEIPT MAILED
06/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/25/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/20/2021
Continuous trademark protection
Get notified about every new filing that threatens XEGEMDI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.